News About: Pharm. Industry
Astellas Pharma Korea President Hae-Do Jung promoted to ChairmanAstellas Pharma Korea announced Hae-Do Jung, the current president, will be promoted to the chairman on the 1st of April.
Astellas Pharma Korea President Hae-Do Jung was recrui...
|
What are methods for Korean pharmas to receive support when discovering foreign partners?
As announcing to actively support Korean pharmaceutical companies’ localization into new markets, the Ministry of Health and Welfare(MOHW) unveiled details about the plan.
Pharmaceutical Industry Promotion Director S...
Pharmas’ series of drug shortages even in new year
Pharmaceutical companies’ drug shortages continue in the beginning of the year.
According to multiple industries, such as the pharmaceutical distribution industry, both Korean and multinational pharmaceutical compani...
Hanmi Pharm CEO Gwan-Sun Lee, "We’ll promptly resume clinical trials of drug postpone in manufacturing"Hanmi Pharm(CEO Gwan-Sun Lee) has been the Korea’s center of attention for the past 2 years. Hanmi Pharm, which has received the praise as a company to nurture the country’s fut...
|
Celltrion’s Truxima wins all the patent nullification trials in Korea
Celltrion announced the Intellectual Property Tribunal ruled nullification of the patent for the chronic lymphocytic leukemia(CLL) indication owned by Bio-Gen, which is related to the patent of Rituxan, the original p...
Innovative pharmas set 2017’s sales goal at KRW 11 trillion
42 of 47 innovative pharmaceutical companies certified set their sales goal of 2017 at KRW 11 trillion increased approximately by 9.8% compared to KRW 10 trillion in 2016.
The goal was found according to the analysis...
Which are 8 hospitals targeted for the rebate investigation in Gwangju?
The number of client hospitals of the wholesaler investigated by Gwangju Metropolitan Police Agency for rebate has been increased to 8 hospitals.
During the rebate investigation process on the wholesaler and a hospit...
It is ‘good or bad’ to introduce products from multinational pharmas?
CEOs of pharmaceutical company have had different viewpoints over introduced products(merchandise) since the co-marketing between Korean pharmaceutical companies and multinational pharmaceutical companies(Korean pharm...
Dongkoo Bio&Pharma strengthens dermatology lineup with ‘Betatriol’After successfully avoiding the patent of the psoriasis treatment ‘Daivobet(Product name of Dongkoo Bio&Pharma: Betatriol),’ Dongkoo Bio&Pharma(CEO Yong-Jun Cho) is actively wor...
|
Hanmi Pharm records KRW 882.7 billion sales KRW 26.8 billion operating income last yearHanmi Pharm(CEO Gwan-Sun Lee) announced it recorded KRW 882.724 billion sales decreased by 33% and made KRW 26.771 billion operating income and KRW 30.299 net profits, significa...
|
